Insmed Inc (INSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,276,775 | -913,772 | -749,567 | -481,534 | -434,654 |
| Depreciation Amortization | 25,378 | 20,609 | 20,611 | 16,282 | 46,299 |
| Accounts receivable | -88,307 | -12,932 | -11,963 | -6,423 | -8,118 |
| Accounts payable and accrued liabilities | 100,073 | 44,592 | 15,155 | 50,011 | -7,575 |
| Other Working Capital | -80,299 | -3,177 | -39,218 | 6,575 | -58,580 |
| Other Operating Activity | 384,916 | 180,798 | 228,735 | 14,650 | 99,326 |
| Operating Cash Flow | $-935,014 | $-683,882 | $-536,247 | $-400,439 | $-363,302 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -32,561 | -21,923 | -13,288 | -9,878 | -7,289 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -6,704 |
| Purchase Of Investment | -2,092,014 | -1,577,252 | -588,733 | -99,706 | -50,292 |
| Sale Of Investment | 2,090,000 | 1,016,000 | 375,000 | 75,000 | 0 |
| Other Investing Activity | -30,000 | 0 | 3,417 | 0 | 0 |
| Investing Cash Flow | $-64,575 | $-583,175 | $-223,604 | $-34,584 | $-64,285 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 150,000 | 0 | 350,000 | 562,422 |
| Debt Repayment | -4,926 | -2,610 | -1,217 | -601 | -225,000 |
| Common Stock Issued | 958,999 | 1,197,367 | 170,874 | 311,657 | 291,923 |
| Other Financing Activity | 0 | -3,737 | -1,218 | 132,217 | -16,799 |
| Financing Cash Flow | $954,073 | $1,341,020 | $168,439 | $793,273 | $612,546 |
| Exchange Rate Effect | 931 | -1,307 | -250 | -996 | -933 |
| Beginning Cash Position | 555,030 | 482,374 | 1,074,036 | 716,782 | 532,756 |
| End Cash Position | 510,445 | 555,030 | 482,374 | 1,074,036 | 716,782 |
| Net Cash Flow | $-44,585 | $72,656 | $-591,662 | $357,254 | $184,026 |
| Free Cash Flow | |||||
| Operating Cash Flow | -935,014 | -683,882 | -536,247 | -400,439 | -363,302 |
| Capital Expenditure | -32,561 | -21,923 | -13,288 | -9,878 | -7,289 |
| Free Cash Flow | -967,575 | -705,805 | -549,535 | -410,317 | -370,591 |